The aim of this study is to compare the Male Osteoporosis Risk Score and the Osteoporosis Self-Assessment Tool with the gold standard DEXA in determining the risk of osteoporosis in the lumbar and femoral regions in male individuals in the Turkish population, and to investigate their sensitivity and specificity in the first stage of screening for the detection of male osteoporosis.
Eligibility
Sex
MALE
Min age
50 Years
Max age
75 Years
Healthy volunteers
No
İnclusion criteria:
* Men aged 50-75
* Patients who underwent imaging with the STRATOS DEXA device at Kayseri City Hospital
Exclusion criteria:
* Patients younger than 50 or older than 75 years of age
* Patients with secondary osteoporosis
* Female patients
* Patients with uncontrolled severe comorbid conditions
* Patients with a history of pathological fractures
Primary outcome measure(s)
Dual energy Xray Absorptiometry (DEXA) — January 2021-January 2024 DEXA measures bone mineral density (BMD; g/cm2) based on the scanned bone area. T and Z scores are used to interpret DEXA results. The T score indicates how many standard deviations below or above the average BMD measurements of a patient of the same gender and younger adults. The T score should be used for the diagnosis of osteoporosis in postmenopausal women and men over 50 years of age. The Z score indicates how many standard deviations below or above the average BMD measurements of the same gender and age. The Z score should be used for the diagnosis of osteoporosis in premenopausal women and men under 50 years of age. According to the World Health Organization's definition of bone mineral density:
* A T score between -1 and -2.5 SD indicates osteopenia.
* A T score below -2.5 SD indicates osteoporosis.
* A T score below -2.5 SD accompanied by a fragility fracture(s) indicates severe osteoporosis. • A Z-score of -2.0 SD or lower is defined as "below the expected range for age,"
MORES — January 2021-January 2024 The Male Osteoporosis Risk Prediction Score uses age, weight, and history of chronic obstructive pulmonary disease (COPD) to classify the risk of osteoporosis in men aged 50 and older. Values of 6 or higher are the threshold for screening.
OST — January 2021-January 2024 The Osteoporosis Self-Assessment Tool (OSA) screening program is used to improve osteoporosis screening in patients. The main tool of this screening program is the OS, a risk formula based on age and weight. OS has proven to be a reliable screening tool for osteoporosis in both female and male populations. The OS score is calculated using the formula: OST Score = \[Weight (kg) - Age\] x 0.2. Osteoporosis risk:
* High risk: -20 to -4 for women, -20 to -1 for men
* Moderate risk: -4 to -1 for women, -1 to 4 for men
* Low risk: -1 to 20 for women, -4 to 20 for men
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
We use cookies to analyse site traffic and improve your experience. With your consent, we may also use cookies for advertising. You can change your choice at any time.